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3-PGA    3-phosphoglycerate 
ATP     Adenosine Triphosphate 
ACP     Acyl carrier protein 
Kbp     Kilo base pairs 
cDNA     Complementary deoxyribonucleic acid 
dH2O     Distilled water 
DMAPP    Dimethylallyl diphosphate 
DOXP    1-deoxy-D-xylulose 5- phosphate 
EtOH     Ethanol 
FAS II    Fatty acid synthesis Type 2 
GAPDH    Glyceraldehyde 3-phosphate dehydrogenase  
Glc6P     Glucose-6-phosphate 
GPI     Glucose-6-phosphate isomerase 
GPT     Glucose-6-phosphate transporter 
HRP    Horseradish peroxidase 
IPP     Isopentenyl diphosphate 
MeOH    Methanol 
MVA     Mevalonate 
NADPH    Nicotinamide adenine dinucleotide phosphate 
PEP     Phosphoenolpyruvate 
Pi     Inorganic phosphate 
PPT     Phosphoenolpyruvate- phosphate transporter 
pPT     Plastidic phosphate transporter 
rpm     Revolutions per minute 
TgAPT    Toxoplasma gondii apicoplast phosphate transporter 
TPT     Triose phosphate transporter 
tRNA     Transfer ribonucleic acid 
XPT     Xylulose-5-phosphate transporter 








Plastids are plant specific cell organelles, which perform many specialized and essential 
functions. Integration of plastids into cellular metabolism requires an extensive exchange of 
metabolites between plastids and the surrounding cytosol which is catalyzed by more than 150 
different transporters. One of the best-characterized families is the plastid phosphate 
translocator family (pPT). Proteins similar to plant pPTs (APTs) where recently identified in 
Apicomplexa, e.g. in Plasmodium falciparum and Toxoplasma gondii. Parasitic diseases caused 
by these species are one of the most serious medical and economic issues worldwide. The APTs 
show similar activities and substrate specificities as their plant counterparts. Most importantly, 
the disruption of the APT gene in T. gondii leads to immediate death of the parasite which 
clearly shows the importance of this transporter for growth of the parasites. Therefore, there is 
an ongoing project to elucidate the structure of the APT from T. gondii at atomic resolution and 
to analyze the transport mechanism at a molecular level by x-ray crystallography. To achieve 
that goal, the APT protein has to be expressed in a heterologous system. In this study the 
apicoplast phosphate transporter protein was produced by heterologous expression in 
Escherichia coli. The suitable plasmid (pET21b) was selected, covering the TgAPT gene, 
introduced into BL21 RIL strain of E. coli and the recombinant machinery was induced with 
IPTG. The APT protein was engineered with a Twin-Strep®-affinity tag attached to its N-
terminus and was purified by affinity chromatography on Strep-Tactin® resins. The successful 
expression of the APT in E. coli offers the possibility to produce and purify the APT protein in 
larger quantities, and, second, to measure its transport activity directly in the bacterial cells. 
 










1.1 The parasite Toxoplasma gondii causes a disease called Toxoplasmosis 
Toxoplasma gondii is a member of a phylum called Apicomplexa. It is an obligate 
intercellular parasitic protozoan and the causative agent of a disease called Toxoplasmosis. 
Around 30-50% of the world population is infected by this parasite (Pappas 2009). It can affect 
any warm-blooded animal and humans. It is rarely fatal for humans, but in individuals who 
have a weak immune system it can be fatal and lead to death (Flegr et al., 2014). Infection is 
often asymptomatic but immunocompetent individuals may have symptoms like fever, muscle 
pains, sore throat, headache and lymphadenopathy. Severe disease symptoms are usually 
observed only in congenitally infected children and immunosuppressed patients (Dubey 1996). 
Prenatally acquired T. gondii often infects the brain and retina causing mental retardation, while 
the ocular disease is the most common injury with mild symptoms consisting of slightly 
diminished vision. Immunosuppressed patients may have a central nervous system disease like 
encephalitis which is an acute infection and inflammation of the brain itself. (Tenter et al., 
2000).  
Toxoplasma gondii causes diseases also in animals and is the major cause of abortion in 
sheep and goats. Cats, dogs and other pets can die of pneumonia, hepatitis and encephalitis if 
they were exposed to Toxoplasmosis. Humans and animals are intermediate hosts, while 
members of the family Felidae (mainly domestic cats) are the only definitive hosts, where T. 
gondii reproduces sexually (Tenter et al., 2000).  
The life cycle of T. gondii consists of three stages: sporozoites (in sporulated oocysts 
which are shed in feces of cats), tachyzoites (which are a rapidly multiplying form found in all 
tissues) and bradyzoites which are the cyst resting form (Sonar et al., 2010). Infection is 
contracted when cats ingest either oocysts or meat containing live organisms shown in Figure 
1. Bradyzoites are released in the stomach tissues containing cysts. They penetrate the epithelial 
cells of the small intestine and initiate the formation of asexual generations before the sexual 
cycle begins (Dubey 1996). The parasites then enter the intestinal epithelium and can be spread 
to many host tissues. Parasites infecting the intestinal epithelium produce oocysts which are 
shed in the feces in a non-sporulated stage. Sporulation occurs outside the body and oocyst 
become infectious 1-5 days after excretion. They are resistant and can survive in soil for several 
months (Schlüter et al., 2014). Secondly, other bradyzoites in the epithelium begin to multiply 
as tachyzoites. Tachyzoites can enter almost any type of host cell and multiply until the host 
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cells are filled with parasites and finally die. Then the released tachyzoites enter a new host cell 
and multiply there (Dolores et al., 2015). 
There are three main modes of T. gondii transmission: congenitally, by eating raw or 
undercooked infected meat of sheep, goat, pigs and rabbits, and via fecal matter by ingesting 
food and water contaminated with oocysts from infected cat feces (Hill and Dubey 2002). The 
infection can also occur by organ or bone marrow transplantation (Tenter et al., 2000), playing 
in sandboxes and school play- ground contaminated with oocysts from infected cat feces, 
contact with contaminated  soil and gardening without gloves, contact with contaminated water, 
insufficient washing of contaminated vegetables and fruits (Schlüter et al., 2014). Tachyzoites 
play the major role in the vertical transmission of T. gondii and they have been found in the 
milk of the goat. It is also assumed that the infection can occur by consumption of unpasteurized 
goat milk (Tenter et al., 2000).  
  
Figure 1. Life cycle of Toxoplasma gondii 
A) enteroepithelial replication occurs in the cat intestine after ingestion of oocytes from fecal 
contamination or bradyzoites within tissue cysts. Ingested bradyzoites can also undergo merogony to 
form micro- and macrogamonts. An unsporulated oocyst is eventually formed after union of gamonts. 
B) the oocyst is excreted unsporulated in the feces and is noninfectious. It sporulates in the environment 
and becomes infectious. Then it can be ingested by a variety of intermediate hosts. C) muscle and tissue 
encystment occur in the intermediate host. In females, infected for the first time during pregnancy, 
congenital infection of the fetus occurs. Figure is taken from Dubey et al., 2009. 
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1.2 The phylum Apicomplexa 
The phylum Apicomplexa is a large and diverse monophyletic group that comprises more 
than 5000 parasitic species (Figure 2) (Wiser 2011). Some of this species infect humans and 
several others are considered important pathogens for warm-blooded animals. Apicomplexan 
genera, which infect humans, are Plasmodium species which are the causative agent for malaria, 
Cryptosporidium spp. (cryptosporidiosis) and Toxoplasma gondii (toxoplasmosis) which cause 
benign diseases if the host has an intact immune system but can cause serious disease in 
immunocompromised hosts. Most important apicomplexan genera in veterinary medicine and 
agriculture are parasites like Babesia spp. and Theileria spp. in cattle and Eimeria spp. 











All these parasites are obligate intracellular parasites. They live inside of host cells, which 
can be an animal and human cells. During their invasion, the parasites form a membrane which 
forms vacuole, called parasitophorous vacuole membrane in which parasites live (Lingelbach 
et al., 1998). The cells of Apicomplexa possess the typical eukaryotic organelles like the 
nucleus, the Golgi apparatus, the endoplasmic reticulum, and two endosymbiotic organelles- 
mitochondria and plastids. The parasites also possess unique organelles like the apical complex 
(conoid) located at the apical end of the parasite, where the invasion occurs, and rhoptries and 
micronemes that play a key role in invasion (Mehlhorn 2016). The main organelles are shown 




Figure 3. Main organelles in Toxoplasma gondii. Figure is taken from Black and Boothroyd 2000. 
 
Phylogenetic analysis indicates that members of the genus Colpodella formed a sister 
group with the apicomplexan (Kuvardina 2002). Colpodellids are predatory flagellates and with 
the process called myzocytosis, they are feeding on unicellular algae. Myzocytosis is a feeding 
method, which involves attachment of the predator to the prey and sucking out the cellular 
content (cytoplasm) of the prey via specialized structures similar to those that apicomplexan 




1.3 The apicoplast derived from a red algae chloroplast 
The apicoplast is a plastid-like organelle found in parasites of the phylum Apicomplexa. 
It is considered to be a vestigial plastid because it is not green and it does not perform 
photosynthesis. The name APICOPLAST is derived from APICOmplexa + PLASTid (Kohler et 
al., 1997). The apicoplast originated from a secondary endosymbiosis, i.e. a process where a 
eukaryotic cell engulfed another eukaryotic cell bearing plastids that had been obtained by 
primary endosymbiosis. In the primary endosymbiotic event, an early eukaryotic cell took up a 
cyanobacterium that was eventually transformed into a plastid. These primary plastids, such as 
those found in red and green algae, glaucophytes and plants are characterized by two 
surrounding envelope membranes (McFadden and Roos 1999). After primary endosymbiosis, 
plastids are thought to have been transferred by secondary endosymbiosis laterally into several 
eukaryotic lineages that normally lacked plastids (Keeling 2010). In the case of Apicomplexa, 
the endosymbiont was a red alga (Janouskovec et al., 2010).  
The indication of secondary endosymbiosis is the existence of three or four membranes 
surrounding the plastids (Gould et al. 2008). For example, it has been shown that the apicoplast 
in T. gondii has four envelope membranes (Figure 4) (Kohler et al., 1997; McFadden et al., 
2016). The four envelope membranes have different origins. First, the outer membrane of the 
apicoplast is homologous to the host endomembrane system. The second membrane originates 
from the plasma membrane of the red alga. The two inner membranes correspond to the 
envelope membranes of the primary plastid (Fast et al., 2001). 
The apicoplast is considered to be essential for the survival of the parasite. Beside its 
basic metabolic processes such as DNA replication, transcription and translation (Brooks et al., 
2011; Dahl and Rosenthal 2008), they also have enzymes involved in anabolic pathways like 
the synthesis of fatty acids, isoprenoids and haem (Ralph et al., 2004). These pathways are 
fundamentally different from the equivalent eukaryotic pathways of the animal or human hosts 
and that is why apicoplasts are interesting to study as potential drug targets (McFadden et al., 







     
 
Figure 4. Toxoplasma gondii 
 a) is showing transmission electron micrograph of T. gondii with nucleus (Nu), endoplasmic reticulum 
(ER), Golgi apparatus (Go), apicoplast (Ap), mitochondrion (Mi), plasma membrane (PM) and alveoli 
(Alv). b) is showing apicoplast (Ap) and mitochondrion (Mi) in a close association and apicoplast 
surrounded with four membranes. Figure is taken from McFadden 2010. 
 
 
An important aspect of the metabolism of intracellular pathogens is the acquisition of 
lipids and fatty acids. Fatty acids are playing an important role in the post-translational 
modification of numerous proteins and they are main building blocks of membranes and are 
main storage compounds (Waller and McFadden 2005; Ramakrishnan et al., 2012). In nature, 
there are two types of fatty acid biosynthesis, Type I found in animals and fungi, and Type II 
found in bacteria, plants and parasites (White et al., 2005). In eukaryotes, fatty acid synthesis 
occurs in two subcellular compartments, namely in the cytoplasm and in mitochondria. In 
plants, there is another pathway in plastids. Animals and fungi use FAS type I (FASI) found in 
the cytosol. Bacteria uses FAS type II (FASII) complex where each enzymatic domain is a 
discrete polypeptide. In plants and algae, fatty acid synthesis takes place in plastids and utilizes 
the FASII enzyme complex. Apicoplasts, like other plastids, possess the FASII pathway (Waller 
et al., 1998; Ramakrishnan et al., 2012). FAS I and FASII pathways differ in structure, kinetic 
and susceptibility to several inhibitors. Properties that makes them different also makes them 
attractive targets for the development of parasite-specific drugs. It has been proven that the 
apicoplast FASII pathway is essential for the parasite viability (Mazumdar et al., 2006).  
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Apicoplasts have a pathway to synthesize isopentenyl diphosphate (Jomaa et al., 1999) 
that is essential for the growth and survival of T. gondii (Nair et al., 2011). Isoprenoids are lipid 
compounds with many important functions, and all of them depend on the precursors like 
isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP). These two precursors 
are used to synthesize a wide variety of lipids (Lim and McFadden 2010; Nair et al., 2011).  
Isoprenoid synthesis in apicomplexan parasites differs from the one which occurs in animals 
and fungi, meaning that the common precursor IPP can be produced by two different 
biosynthetic routes, either via the mevalonate pathway (MVA), or the 1-deoxy-D-xylulose 5-
phosphate pathway (DOXP). The DOPX pathway is used by most eubacteria, a green alga 
(Scenedesmus obliquus), liverwort and plants but is absent in mammals. Plants and some algae 
possess both pathways, with MVA localized in the cytosol and DOXP in plastids (Disch et al., 
1998; Waller and McFadden 2005). 
Heme metabolism is critical for parasite survival (van Dooren et al., 2012). Heme is 
required for mitochondrial respiration and the initial step of this pathway starts in mitochondria 
but some subsequent reactions of the pathway are taking place in the apicoplast and it terminates 
in the mitochondrion. Heme is a prosthetic group of hemoglobin, myoglobin, and the 
cryptochromes, essential for most life on Earth. It functions in numerous cellular redox 
reactions like antioxidant defenses and at several stages of the electron transport chain in 
prokaryotes and eukaryotes and as sensor and transport molecule for oxygen (van Dooren et 
al., 2012). The heme synthesis is described in Figure 5. The loss of photosynthesis in 
Apicomplexa meant that tetrapyrroles were no longer required in the plastid. The terminal steps 
of heme biosynthesis then shifted back to the cytosol and mitochondrion, reflecting the pathway 
that exists in P. falciparum and T. gondiii (van Dooren et al., 2012). In animals and in fungi, 
heme is an end-product of the tetrapyrrole biosynthesis pathway. In plants, tetrapyrrole 
biosynthesis pathway produces both heme and chlorophyll (Ralph et al., 2004). 
All these anabolic pathways are driven by carbon sources, which are imported from the 
parasite’s cytosolic glycolytic pathway, using transporters located in the inner membrane of the 
apicoplast (McFadden 2014). Non-photosynthetic plastids import fuel using specific metabolite 







Figure 5. Heme biosynthesis in Toxoplasma gondii and Plasmodium falciparum 
Heme biosynthesis begins with the aminolevulinic acid synthesis (ALAS)- catalyzed formation of 
aminolevulic acid (ALA) in the mitochondrion of T. gondii and P. falciparum. ALA is then transported 
from the mitochondrion into the stroma of the apicoplast. In apicoplast, four reactions of heme synthesis 
take place, leading to formation of coproporphyrinogen III. Coproporphyrinogen III is exported from 
the apicoplast into the cytosol where the CPO enzyme oxidizes coproporphyrinogen III forming 
protoporphyrinogen IX. Figure is taken from van Dooren et al., 2012. 
 
 
1.4 The Toxoplasma gondii apicoplast phosphate transporter 
In higher plants, carbon skeletons from photosynthesis are exported in the form of triose 
phosphates by the triose phosphate/ phosphate transporters (TPT) (Flügge 2003). The TPT is 
one of the members of a large family of plastid phosphate transporters (pPT). The other 
subfamilies catalyze the import of metabolites into plastids like phosphoenolpyruvate (PEP) 
(by the PEP transporter PPT), glucose 6-phosphate (by the GPTs) and xylulose-5-phosphate 
(by the XPT) (Fischer and Weber 2002). T. gondii possesses only one plastid phosphate 
transporter, suggesting that this protein is transporting more than one substrate. It is localized 
in the inner envelope membrane of the apicoplast and its functions as antiporter, where a sugar 
phosphate is translocated in exchange for inorganic phosphate (Fleige et al., 2007). 
Because the apicoplast is a non-photosynthetic organelle the lack carbon fixation, and 
ATP and NADPH production has to be compensated by the import of compounds from the 
cytoplasm into the apicoplast to drive this anabolism (Fischer and Weber 2002). Apicoplasts 
also lack hexose- or pentose-processing pathways. Therefore, apicoplasts import C3 
compounds like triose phosphates and PEP from the cytosol to fuel its anabolic pathways (Ralph 
et al., 2004). 
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The Toxoplasma gondii apicoplast phosphate transporter (TgAPT) is able to transport 
triose phosphates, PEP, and 3-PGA but it does not possess Glc6P transporter activity (Brooks 
et al. 2010). It is required for the activity of the FASII pathway, providing a direct link between 
cytoplasmic and apicoplast metabolism (Figure 6). A second pathway which depends on this 
transporter is the DOXP pathway (Brooks et al., 2011). In addition, TgAPT is linking cytosolic 
and plastid isoforms of phosphoglycerate kinase, GAP-DH and triose phosphate isomerase. 
GAP-DH and PDH are the only enzymes identified in apicoplasts which produce redox 
equivalents in form of NADH or NADPH. Phosphoglycerate kinase and pyruvate kinases are 
the only enzymes which are producing ATP (Brooks et al., 2011). The import of DHAP from 
the cytosol via TgAPT would then be followed by its conversion into glyceraldehyde-3-
phosphate (GA3P) and via two steps into 3-phosphoglycerate (3-PGA), releasing NADPH and 
ATP. The 3-phosphoglycerate produced would be exported to the cytosol, via TgAPT 





Figure 6. TgAPT links apicoplast metabolism to the parasite cytoplasm 
Schematic representation of main anabolic pathways in apicoplast. Note that TgAPT serves as a hub to 
supply carbon (through PEP and triose phosphate) as well as energy and reduction power through the 
triose shuttle. TgAPT is a phosphate antiporter and Pi is not shown for simplicity. This figure is taken 






Disruption of the TgAPT protein leads to rapid death of the parasite which clearly shows 
the importance of this transporter for its growth. The TgAPT delivers the carbon skeletons for 
fatty acid biosynthesis and the isoprenoid pathway, meaning it is considered to be the main 
source of carbon for these essential apicoplast anabolic pathways. In addition, it has an essential 
role in delivering redox equivalents and ATP to apicoplasts, suggesting that targeting this 




1.5 Escherichia coli as expression system  
The expression of the APT protein from T. gondii was already established in yeast 
(Brooks et al., 2011) and with our collaborators in Grenoble. However, because protein 
production in yeast is time-consuming and expensive, this project is focused on the production 
of the APT protein in a bacterial system, namely the model organism Escherichia coli. E. coli 
is a gram-negative, facultatively anaerobic bacterium. Gram-negative bacteria contain a distinct 
surface composed of inner and outer phospholipid membranes and a rigid peptidoglycan cell 
wall between these two layers. This structure allows them to adjust and adapt themselves to 
different temperatures, stress and environments (Ron 2013). 
The optimal growth temperature of E. coli cells occurs around 37°C. They reproduce via 
an asexual process called binary fission in which each cell increases in size and divides into 
two cells (Kenweth 2002). The cells will increase in number, under optimum conditions, until 
they reduce the nutrients in the medium. The cells will then undergo a physiological change 
which is allowing them to survive in the absence of growth. This state is called stationary phase 
where the number of cells increases barely slow. The cell density is highest in the stationary 
phase where most E. coli strains appear to contain a high amount of plasmids. Therefore the E. 
coli cells at the stationary phase are mostly used for plasmid production. The stationary phase 
is then diluted with fresh medium and then the bacteria undergo another physiological change 
and start to divide at an exponential rate known as the logarithmic phase (log phase). This cell 
growth can be measured with a spectrometer by following the increase in absorption of a culture 
at 600 nm and by checking the optical density (OD) at different time periods. A culture with an 
absorbance of 1.0 OD contains approx. 2x108 cells /ml (Kenweth 2002).  
The heterologous expression of proteins is a commonly used technique to produce 
proteins for molecular biological examinations. There are different expression systems now 
available like yeast, insect cells, mammalian cells and amoeba (Dictyostelium discoideum), but 
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the most widely used systems are still bacteria like E. coli. A large number of cell lines and 
expression vectors are available and because the transfection and growth of this bacteria are 
simple, fast and cheap and it is the most commonly used system for protein production in the 
laboratory and industry (Doyle 2008). However, there is no universal expression system for 
heterologous proteins. All expression systems have some advantages as well as some 
disadvantages (Rai 2001). The use of expression systems such as insect or mammalian cells has 
their own drawbacks. In the insect system baculovirus is used to transfect the cell line and 
working with viruses is not as easy as with bacteria. Mammalian systems are time-consuming, 
expensive and difficult to perform at the large scale (Terpe 2006). Large scale production of 
engineered proteins is crucial for structural and functional analysis and therapeutic and in vivo 
studies. For most recombinant protein expression systems the main goal is to achieve fast, 
inexpensive expression of proteins which are easy to purify and could be produced in large 
quantities (Gräslund 2008). To increase the production of the proteins the first step is to 
optimize the expression conditions to avoid aggregation, degradation and improper folding. 
Protein expression is highly dependent on the choice of vector, cell strain and conditions like 
temperature and medium. 
Several factors may affect protein expression. For instance, selection of a proper cell 
strain is an essential factor that needs to be considered during bacterial transformation and 
expression. There are a great variety of cell strains that can be used in order to express proteins 

















1.6 Objectives of this study 
The main goal of this master thesis is the expression of the TgAPT in E. coli for two 
reasons. First, the establishment of an expression and purification protocol for the APT protein 
paves the way towards the molecular analysis of the protein which might finally lead to the 
design of new drugs against Toxoplasma and Plasmodium. Second, E. coli cells expressing a 
functional APT protein could be directly used for transport experiments with different 
substrates, thereby characterizing the transport activities of the APT.  
 
This program involves the following steps: 
 
1. An E. coli expression vector containing the APT gene will be introduced into different 
E. coli strains. The vector with the APT gene was synthesized by our collaborator in 
France. 
2. The different transformed E. coli strains will be screened for the best expression. For 
that, a large number of transformed cells will be analyzed for APT expression, which 
includes the following steps: 
a. Growth of transformed clones in liquid media 
b. Protein isolation from the cells 
c. Detection of the APT protein by a specific antibody against an N-terminal Strep-tag 
3. Clones with the highest expression level will be grown at larger scale. 









Table 1. Materials used in project 




Tryptone  10 g  
NaCl  10 g  
Yeast extract  5 g  
dH2O  Add to 1 l  
Solid medium 
for E. coli 
 
200 ml 
Peptone  2 g  
Yeast extract  1 g  
NaCl  2 g  
Agar powder  2 g  
dH2O  Add to 200 ml  
Resuspension 









NaCl 300 mM 5 M  
10 mM MgCl2 1 M 125 µl  
Glycerol 5% 100 % 150 µl  
PMSF 1 mM 1000 mM 25 µl  
DNase  2.5 µl  









NaCl 300 mM 5 M 
  











NaCl 300 mM 5 M  
DDM 0.5 % 20 % 250 µl 
 












NaCl 300 mM 5 M  
DDM 0.5 % 20 % 65 µl  





DDM 20% 10 mg  
dH2O  Add to 50 ml  
DTB 50 ml 
DTB 25 mM 268 mg  




































1 M TRIS 












 6 ml 
2.5 ml 
100 µl  






1 M Tris  
pH 6.8 
250 mM 800 µl 
 
Glycerol 50 % 2 ml  
20 % SDS solution 




1 M Tris pH 6.8 






Tris base 250 mM 30.3 g  
Glycine 2 M 150 g  
SDS 1% 10 g  




Tris base 25 mM 3.03 g  
Glycine 192 mM 14.4 g  
MeOH 20% 200 ml  
dH20  Add to 1000 ml  
10x TBS-T 1 l 
Tris base 100 mM 12.11 g  
NaCl 1.5 M 87.66 g  
Tween-20 0.5% 5 ml  
Triton-x100 2% 20 ml  













and then add 
dH2O 
MeOH  100 ml 
dH20  100 ml 




Acetic acid 7.5 %   
MeOH 10 %   
 
Table 2. Commercial kits used in project 
Q5® High-Fidelity 2X Master Mix PCR New England BioLabs® 
NucleoSpin® Gel and PCR Clean-up Cleaning up the PCR MACHEREY-NAGEL 
NucleoSpin® Plasmid DNA purification Purification of plasmid MACHEREY-NAGEL 
Rapid DNA Ligation Kit DNA ligation with sticky ends Roche 
Mini-PROTEAN® TGX™ Precast gel Precast gels BIO-RAD 
SIGMAFAST 3,3′-Diaminobenzidine 
tablets 
Localization of peroxidase 
activity 
Sigma-aldrich 
SuperSignal® West Pico 
Chemiluminescent Substrate 
Detection of protein after 
plotting 




2.2 Cloning procedures 
Cloning of the TgAPT into the expression vector was done by collaborating colleagues 
from IBS in Grenoble. The vector used for the expression of targeted protein was pET21b+ 
(Appendix I) and construct of the affinity-tagged protein was designed by the GeneScript. 
PCR with plasmid DNA was performed in small 200 µl tubes and with Q5® High-fidelity 
2x Master Mix kit (New England BioLabs®) and primers were already pre-ordered. Master-mix 
was already prepared inside kit containing Mg2+, deoxynucleotides and DNA polymerase. 
Primer concentration was 18.1 nM. For the control, a sample without the DNA was used. The 
PCR reaction was done according to Table 3 and everything was added into PCR tubes and 
program was setup like in Table 4.  
 
Table 3. The PCR reaction 
For 25 µl reaction: 
Nuclease- Free water 10 µl 
Q5 High-Fidelity 2x Master Mix 1.25 µl 
Forward primers 1.25 µl 
Reverse primers  1.25 µl 
DNA Template 
1 µl 
    
 
Table 4. The PCR setup 
PCR setup: 
98˚C 30 sec  
98˚C 7 sec 
30 cycles 
66˚C 20 sec 
72˚C 42 sec 
72˚C 2 min 
 
 
The PCR reaction was analyzed by agarose gel electrophoresis. The DNA after PCR was 
purified with spin columns with NucleoSpin® Gel and PCR Clean-up kit (Macherey-Nagel). 
Purification was done according to the manufactural manual. Restriction digestion of the PCR 
fragments was done with the two restriction enzymes Ndel and HindIII in Cut Smart™ buffer 
(New England BioLabs®) for two hours at 37˚C. After incubation, the digested fragments were 
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purified with NucleoSpin® Plasmid Quick Pure kit (Macherey-Nigel) and DNA fragments were 
separated with the agarose gel electroporation.  
Plasmid purification was done according to the manufactural manual. Gel slices with 
good quality band were cut under the UV light and placed into new tubes and solubilized with 
NucleoSpin® Gel and PCR cleanup kit (Macherey-Nagel). Solubilization was done according 
to the manufactural manual. For the ligation of vector and insert, the DNA concentration was 
measured using spectrophometer (Nano Drop) because the vector and insert should be in 
equimolar concentration. Ligation was done with Rapid DNA ligation kit provided by Roche 
and according to the manufactural manual and described in Table 5. 
 
Table 5. Ligation reaction 
1. Tube- APT PCR 2. Tube- Vector 
47 µl dH2O 58 µl dH2O 
8 µl Cut Smart™ buffer 8 µl buffer 
20 µl DNA 9 µl DNA 
2.5 µl enzyme (Ndel) 2.5 µl enzyme (Ndel) 
2.5 µl enzyme (HindIII) 2.5 µl enzyme (HindIII) 
 
The first tube contained 40 mg/ µl and second had 10 mg/ µl of sample. To each sample 
10 µl of ligation buffer was added and 2.5 µl of vector and 6.5 µl of APT insert. At the end 1 
µl of T4 ligation enzyme was added, mixed well and stored on -20˚C. 
 
 
2.3 Testing different strains for protein expression 
To get the highest expression of TgAPT protein, different E. coli strains were tested. The 
transformation was done with the heat-shock protocol (see below) and TgAPT vector was 
inserted into six different E. coli strains (BL21 DE3, BL21 RIL, C41, C43, Rosetta, Rosetta 
PLys and PET21b, which contained an empty vector and was used as negative control). Cells 
were grown on solid agar plates with Luria-Bertani (LB) broth medium and Ampicillin (AMP; 
(100 µg/ml)) and Chloramphenicol (CHL; 25 µg/ml) antibiotics. Isolated colonies were 
transformed into small liquid cultures with 6 ml LB medium and AMP (100 µg/ml) and CHL 
(25 µg/ml) antibiotics. Samples were incubated at 37°C overnight in a shaking incubator. The 
following day, cells were transferred into a bigger culture with 250 ml LB medium and 
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antibiotics, and incubated on a shaking incubator at 37°C for approx. 4 hours (until an OD600 of 
0.6-0.8 is reached which represents the middle of their log growth phase). At that time point, 
Isopropyl-beta-D-thiogalactoside (IPTG, 1 mM) was added to each flask and the cells were 
incubated at 20°C overnight in a shaking incubator. Cells were centrifuged (20 min/ 4000 rpm/ 
4°C) and the supernatant was decanted. Pellets were transferred into new 50 ml falcon tubes 
and stored at -20°C overnight.  
The pellets were resuspended in the 600 µl resuspension buffer (50 mM NaPi pH 8, 200 
mM NaCl, 1 M MgCl2, 100x CLAPA and 5% glycerol). Cells were lysed with a sonicator 
(Ultrasonicator UP50H (cycle: 0.5; amplitude: 50%)). Each sample was exposed for a total of 
two minutes with intervals of 10 sec sonication and 10 sec on ice. Samples were centrifuged 
again (20 min/ 15000 rpm/ 4˚C) to remove the insoluble cell content. The supernatant was 
transferred into new Eppendorf tubes and both pellets and supernatant were prepared for 
western blot analysis. 
 For the gel electrophoresis, Mini-PROTEAN® TGX stain-free™ precast gel (BIO-RAD) 
was used and into each well 15 µl of sample/ loading dye was added (24 µl supernatant+ 6 µl 
loading dye; 15 µl pellet which was resuspended in 500 µl resuspension buffer+ 15 µl loading 
dye). Electrophoresis was running for 50 min at 50 mA. Western blot was done with Trans-
blot® Turbo™ system (BIO-RAD) and run it for 7 min with 30 ml Trans-blot® Turbo™ 5x 
transfer buffer (BIO-RAD) + 10 ml dH2O + 10 ml EtOH. Nitrocellulose membranes were 
blocked with blocking buffer (2.5 g milk powder+ 50 ml 1x PBS and 0.03% Tween 20) and 
incubated with the Strep-MAB-classic-HRP antibody (IBA). Detection was done with 
SigmaFast™ 3.3’- Diaminobenzidine (Sigma-Aldrich). 
 
2.4 Preparation of competent cells 
Bacterial culture were chilled on ice for 10 min and the flask was swirled periodically. 
After centrifugation (10 min/ 3200 rpm/4°C), the cells were harvested. The supernatant 
containing medium was decanted and the pellets which contained the cells were gently 
resuspended in 1:10 volume of ice-cold 0.1 M CaCl2. CaCl2 is used to transform bacterial cells 
with the disruption of the phospholipids in the cell membrane allowing plasmid to enter the cell 
through the disrupted cell membrane. Cells were incubated at 4°C for 20 min. After short 
incubation, cells were recovered by centrifugation (10 min/ 32000 rpm/ 4°C). The supernatant 
was decanted and pellets were gently resuspended in 1:50 volume of ice-cold 0.1 M CaCl2. 




2.5 Transformation of E. coli cells 
Competent E. coli cells were thawed on ice. The ligation mixture of the APT plasmid 
DNA (10 ng) was added to the 200 µl BL21 RIL competent cells and incubated for 30 min on 
ice, allowing the plasmid DNA to bind to the cellular membrane. The cells were then subjected 
to heat shock at 42˚C for 90 seconds in a heat block and placed back on the ice for 2 min before 
adding 1 ml of LB medium. The cells were then incubated at 37˚C for 1 hour in a heating block, 
and gently inverted every 15 min. This is allowing cells to recover from the heat shock and for 
the transformed cells to express antibiotic resistance genes. 
Transformed cells were plated into two different volumes (100 µl and 400 µl) on agar 
plates with Carbenicillin (CARB (20 µg/ ml)) and Chloramphenicol (CHL (100 µg/ ml)) 
antibiotics. Inoculation was done overnight at 37˚C. 
 
2.6 Growth of bacterial cells and induction of protein expression 
Bacteria with inserted plasmid was introduced into liquid media with appropriate 
antibiotics and everything was done in sterile conditions. Into small glass tubes, 5 ml of LB, 10 
µl of CHL (100 µg/ ml) and 10 µl of CARB (20 µg/ ml) was added. Using a sterile toothpick, 
a single colony from the plate was picked and mixed together with medium and antibiotics. 
Bacterial culture was incubated overnight at 37˚C with constant shaking (200 rpm).  
Next day the samples had to be diluted and re-grown in bigger culture. Into new 50 ml 
glass flasks 10 ml of medium was added together with 500 µl of small culture and 4 µl of CHL 
and 4 µl of CARB antibiotics. Incubation was done for 2 hours at 37˚C in a shaking incubator. 
Again, everything was done under sterile conditions. 
After approx. two hours, when the OD600 (SmartSpec. 300 – BIO-RAD) was between 1 
and 1.6, the cells were induced with IPTG (1 mM). Only the sample which was used as a 
negative control was not induced. All samples were incubated overnight at 20˚C with constant 
shaking (200 rpm). 
 
2.7 Cell lysis and membrane preparation 
After overnight induction, the samples with were centrifuged (10 min/ max. speed/ 4˚C) 
and the supernatant was decanted and pellets where stored at -20°C. After one hour, pellets 
were resuspended in buffer (described in Materials) and transferred into new Eppendorf tubes 
and kept on the ice through the whole procedure. 
Cells were lysed with a sonicator (10 seconds on, 1 minute break (Branson Sonifier 250; 
cycle 50%; output control 5)). After the cells were disrupted, samples were centrifuged (10 min/ 
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13500 rpm/ 4°C) to remove cell fragments. Pellets were resuspended in 300 µl buffer 
(50 mM NaPi pH 7.8+ 300 mM NaCl) and booth, pellets and supernatant were taken for further 
solubilization and purification. 
 
2.8 Solubilization 
Membrane proteins were solubilized by adding 1% w/v DDM detergent and 500 µl Strep-
Tactin® Sepharose® (IBA) resin was added. The resin was previously washed three times with 
B1 buffer and centrifuge (1 min/ 5 000 rpm/ 4˚C), each time removing the supernatant was. 
Samples were then incubated for 45 min on a rotating wheel at 4°C. 
 
2.9 Affinity chromatography purification on Strep-Tactin® resin 
First, the gravity column was washed one time with 500 µl of B1. Next, the samples were 
loaded into column and flow trough was collected into new Eppendorf tubes. Second, the 
column was washed 10x with 500 µl of B2 buffer. Last, the columns were eluted with 800 µl 
of B3 buffer and incubated for 5 min. after incubation, the elution was collected into new 
Eppendorf tubes. All buffer concentrations are described in Materials. 
 
2.10 SDS -PAGE, Coomassie staining and Western blot 
Proteins were separated by SDS-PAGE on 12% polyacrylamide gels performed 
according to the Laemmli protocol from 1970. The resolving gel was prepared (described in 
Materials), allowing to polymerize on the bottom of the cast before pouring the stacking gel 
(preparation described in Materials) on top. Due to the higher acrylamide percentage in the 
separating gel, the proteins will be concentrated on the interface between the two gels resulting 
in increased protein resolution. After complete polymerization, the chamber was assembled and 
running/ Laemmli buffer (described in Materials) was poured into the well. Each membrane 
pellet was solubilized in 300 µl buffer (50 mM NaPi pH 7.8+ 300 mM NaCl). Aliquot of 60 µl 
of sample was placed into new Eppendorf tubes and 20 µl of loading die (2x SDS-PAGE 
loading buffer) was added. Samples were loaded into the gel (20 µl per lane. In this study, 
PageRuler™ Prestained Protein Ladder (Thermo Fisher Scientific, #SM0671) were used as size 
markers. The electrophoresis was run for 1 hour at 15 mA and after one hour, it was increased 
for 5 mA (per gel) with the constant 250 V.  
The protocol is based on staining and destaining method with the Coomassie blue dye 
R-250. The SDS gel was first washed with dH2O to remove the SDS and the salts from the 
buffer, which interfere with a binding die to the protein and discard the rinse by decanting. The 
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gel was stained with Coomassie blue staining solution (described in Materials) overnight on a 
shaker at RT. Following day, staining solution was removed and the gel was quickly washed 
with water and the destaining solution (described in Materials) was added. Incubation was done 
for 30 min on shaker at RT. Dye that is not bound to protein diffuses out of the gel during 
destaining steps (Biji et al., 2012). Second washing and destaining step was repeated and 
incubation was done under the same conditions only for 1 hour. All liquid was removed and the 
gel was washed with water and equilibrated in the water so it could return to its original 
dimensions. The proteins were detected as blue bands on a clear background 
In this study, the protein samples were separated by SDS-PAGE before they were 
transferred to a Polyvinylidene Fluoride (PVDF) membrane (#162-0177, BIO-RAD) with the 
western blotting. The proteins were detected with SuperSignal® West Pico (#34077, Thermo 
Fisher Scientific) and Strep-Tactin HRP enzyme conjugates. The blot was built from the anode 
side starting with three sheets of filter paper soaked in transfer buffer (described in materials). 
On the top of that filter paper the membrane, which was incubated in MeOH was placed. The 
SDS-PAGE gel was put on top of the membrane and covered with three more filter papers, also 
soaked in the transfer buffer. The system was closed and current was applied for 24 min and 1 
mA per 1 cm2 membrane. After blotting, the membrane was transferred into blocking solution 
(50 ml of 1xTBS-T + 2 % milk powder) and incubated overnight at 4˚C on a shaker. Following, 
the membrane was washed twice for 10 min in 1xTBS-T buffer. The buffer was decanted and 
antibody solution was added (1% milk powder + 50 ml of 1x TBS-T + 10 µl Strep-Tactin HRP 
conjugated) and the membrane was incubated for 2 hours on a shaker at RT. The membrane 
was washed twice with 1xTBS-T buffer for 10 minutes. Detection was done with Super 
Signal® kit (Thermo Fisher Scientific) and equal volumes of stable peroxide and enhancer 
solution (400 µl) were mixed and added on the membrane. The membrane is placed then, 













3.1 Overview about the study 
 
 
Figure 7. Flow chart displaying main steps in methodology, describing all the methods performed at 
various steps during this project. 
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Figure 7 shows  an overview about the project. In order to achieve the expression of the 
Toxoplasma gondii apicoplast phosphate transporter (TgAPT), the cDNA, which encodes the 
transporter protein with the N-terminal Twin-Strep®-tag sequence was cloned into the E. coli 
expression vector pET21 b+ (Novagen). To achieve the best heterologous expression, the new 
plasmid was transferred into different E. coli strains. The best-expressing E. coli strain BL21 
RIL was used for protein production. Cells were disrupted by sonication and the extract was 
separated into soluble and insoluble fractions by centrifugation. The proteins were solubilized 
with the detergent n-Dodecyl-β-D-Maltoside (DDM) and purified using affinity 
chromatography on a matrix carrying an engineered streptavidin (Strep-Tactin®). Detection of 




3.2 Cloning of the new TgAPT construct 
The TgAPT had been expressed before in yeast with two affinity tags, a His-tag and a 
Strep-tag (see Figure 8; Brooks et al., 2010). Because the purification by streptavidin affinity 
chromatography turned out to be more efficient than by NTA chromatography, a new construct 
for the expression in E. coli was designed with two Strep-tags attached to the N-terminus of the 
APT (Figure 8).  
 
 
Figure 8. Schematic presentation of a) old and b) new TgAPT gene 
His6 and Strep are the two affinity tags, TEV is a protease cutting site; Strep-tag II® is a new double tag, 
Ser-Ala represents a short amino acid sequence inserted as a spacer between the APT protein sequence 









A cDNA encoding the new construct, cloned into a vector, was synthesized by the 
GenScript company.  For cloning into the E. coli expression vector pET21b+ (Novagen; for a 
map see Appendix 1), the APT DNA was amplified by PCR. A strong band of the expected 
length of 1kb (Figure 9) was cut out of the gel and digested with the restriction enzymes Ndel 
(5’-end) and HindIII (3’-end). The APT DNA was then inserted into the expression vector 
which had been cut with Ndel and HindIII. The resulting plasmid was named pET-APT. 
In the case of the pET21b+ vector, induction of protein expression is achieved with 
Isopropyl-beta-D-thiogalactoside (IPTG) which is a non-metabolizable lactose derivate. Its 
structure mimics lactose and it is used to induce protein expression driven by a lactose inducible 
promoter (King et al., 2013). When IPTG is present, it dissociates the lac repressor and that 
allows the T7 RNA polymerase to bind to its binding site thereby starting transcription of the 
inserted gene. If the IPTG is not present, the lac repressor will remain bound to the promoter, 





Figure 9. Analysis of PCR product by agarose gel electrophoresis 
Lane 1) marker Quick-Load® Purple 1 kb DNA Ladder (NEB); lane 2) PCR with plasmid DNA 







3.3 Screening of protein expression in different E. coli strains 
Protein expression is highly dependent on the type of protein, cell strains, temperature, 
medium and vector of choice. Because the expression of membrane proteins in E. coli is 
difficult to achieve several different strains of E. coli have been tested for the expression of the 
APT. The BL21 DE3 strain contains a T7 RNA polymerase gene that is integrated into the 
genome and that is under control of the lacUV5 promoter, which is an IPTG inducible system 
(Kortmann 2015). The BL21 RIL cells contain extra copies of the argU, ileY, and leuW tRNA 
genes. These genes encode tRNAs that recognize the arginine codons AGA and AGG, the 
isoleucine codon AUA, and the leucine codon CUA, respectively (Agilent technologies 
manual). They are important for difficult protein expression, especially when codon bias is a 
problem. Rosetta strains are derived from BL21 lacZY and tuner strains but they carry a pRARE 
derived plasmid (conferring chloramphenicol resistance) that encodes several “rare” E. coli 
tRNA genes. Some of the rare codon genes are AGG/AGA (arginine), AUA (isoleucine), and 
CCC (proline), (Novagen® user protocol). Therefore, these strains are designed to increase the 
expression of heterologous proteins whose genes encode numerous rare E. coli codons. The 
pLysS strain has a plasmid encoding a T7 lysozyme gene that allows the expression of more 
toxic proteins in greater amounts since that gene is a natural inhibitor of the T7 RNA 
polymerase and therefore, the protein expression is tightly regulated. Some membrane-bound 
proteins have been successfully expressed in the C41 and C43 E. coli strains. The strain has a 
mutation in the T7 RNA polymerase gene that reduces the transcription from downstream 
recombinant genes (Mulrooney 2000). 
To achieve the best heterologous expression, the different E. coli strains (BL21 RIL, 
BL21 DE3, C41, C43, Rosetta, Rosetta PLys) were transformed with the plasmid pET-APT. 
Clones from each transformation were grown in liquid culture. For membrane preparation, cells 
were grown overnight at 37°C to an OD600 of 0.8–1.0. Expression was induced by adding IPTG. 
The cells were harvested the next day after overnight incubation at 20°C. After cell lysis, the 
samples were centrifuged to separate insoluble from soluble material (Roy 2015). 
Phenylmethylsulfonyl fluoride (PMSF) protease inhibitor was added to the buffer to avoid 
protein degradation. 
The proteins samples, both supernatant and pellet, were analyzed by SDS-PAGE 
followed by a Western blot. In this study, protein samples from the SDS-PAGE gels were 
transferred to a Polyvinylidene Fluoride membrane (PVDF, BIO-RAD). For the detection of 
the tagged APT protein, Strep-Tactin® labeled with horseradish peroxidase (IBA) was used. 
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The horseradish peroxidase (HRP)-conjugate is used for direct detection of Strep-tagged 
proteins in Western blots without the need of a secondary antibody.  
The highest expression level of the TgAPT protein was observed in the BL21 RIL strain 
(Figure 10b) while the other strains show low or no expression (Figure 10a). The empty vector 
pET21 was used as a negative control and showed no expression. The strongest band runs at 
about 35 kDa which is the expected size for the APT (see black arrow in Figure 10b). This 
protein band was present both in the supernatant and in the pellet. The high background is 
suggesting that there was a problem with the antibody. 
 
 
                          
 
Figure 10. Western blot analysis of TgAPT expression in various E. coli strain 
M.U. - unstained marker (Thermo Fischer #26614); M.P - prestained marker (Thermo Ficher #26616). 













To confirm the results of the first screening, cell pellets from the best-expressing strain 
(BL21 RIL) and the lowest-expressing strain (Rosetta) were analyzed in a second experiment 
(Figure 11). The effect of glycerol on the membrane preparation was also tested. With this 
analysis, it was confirmed that the best expression was achieved with the BL21 RIL strain (see 
black arrow on Figure 11). There was no difference between membrane preparations with 
glycerol or without. Again, a strong background was present, probably due to the specific 





Figure 11. Western blot analysis with Strep-MAB-classic-HRP antibody 
M.U. - unstained marker (Thermo Ficher #26614); M.P. - prestained marker (Thermo Ficher #26616). 
The names different E. coli strains are shown below the blot. P- pellet; M- membrane; G- with the 


















3.4 Screening for expression in different BL21 RIL clones 
The E. coli Bl21 RIL was found to be the only strain expressing the APT. Therefore 
competent cells of this strain were prepared for new transformations. The pET-APT vector was 
transformed into BRL21 RIL cells and more than 10 clones were tested for APT expression. As 
it is shown in Figure 12 the protein expression was achieved in clone number 23 and 25 in the 
pellet while there was no expression or only poor expression found in the other clones. 
Coomassie gels was done with the same samples and protein band cannot be observed probably 




Figure 12. Western blot of supernatant and pellet of different isolated clones after cell lysis and SDS-
PAGE 
The marker was PageRuler™ Prestained Protein Ladder (Thermo Fisher Scientific, #SM0671) and for 




Figure 13. Coomassie blue staining with the same samples as in Figure 12 
The marker was PageRuler™ Prestained Protein Ladder (Thermo Fisher Scientific, #SM0671).  




Protein separation can be used to determine the molecular weight of a protein of interest 
by comparing its migration in the gel with that of marker proteins of known size (Figure 14 
right). For that, the migration distance of the protein marker is plotted against the logarithm of 
the molecular weights (MW) of the proteins as shown in Figure 14 left. This leads to a standard 
curve showing a linear relationship which was used to determine the MW of the APT protein 
(Figure 15). The mobility of the TgAPT protein was found to be 1.48 and the MW of the protein 
was therefore 30 kDa. 
 
                              
Figure 14. Calculation of MW 
The left picture is showing the example how to calculate the MW of unknown proteins (BioRad); The 
right picture is showing PageRuler™ prestained protein ladder (Thermo Fisher Scientific, 





Figure 15. Determination of MW of the TgAPT protein  
Using the formula in the figure, the MW of the APT protein was calculated. 
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3.5 Localization of the APT in pellet and supernatant 
The best expression was achieved with clones 23 and 25. The next step was to repeat the 
expression experiments with only these two clones to confirm the previous results. In addition, 
the distribution of the APT protein between pellet and supernatant was analyzed in more detail. 
The clones were re-grown in liquid culture and, induced with IPTG. There was again an APT 
protein band in the extracts of clones 23 and 25 which was found almost exclusively in the 
pellet fraction (Figure 16) while there was no band in the negative control. The positive control 
of the yeast sample did not show a signal, probably because the sample was too old. 
 
          
 
Figure16. Coomassie staining and Western blot analysis with clone 23 and 25 after lysis 
Gel a) Coomassie stained SDS-PAGE; Gel b) Western blot;,M - marker PageRuler™ Prestained Protein 
Ladder (Thermo Fisher Scientific, #SM0671); P.C.E.c - positive control E. coli expression; N.C. - 
negative control non-induced clone 25; P.C.y - positive control yeast cell expression. Numbers 23 and 












The distribution of the APT protein was analyzed in a second experiment. As shown in 







Figure 17. Western blot analysis  
Blot a) analysis after cell lysis;  M – marker, PageRuler™ Prestained Protein Ladder (Thermo Fisher 
Scientific, #SM0671); N.C. - negative control non-induced clone 25; P.C. - positive control  expression 
from previous experiments; numbers indicate the clones 23 and 25; S - supernatant; P - pellet;  
Blot b) analysis after solubilization with DDM. The arrow points to the APT band. 
 
 
As these results confirmed that the APT protein is present in the pellet and in the 
supernatant, the next step was to solubilize the proteins by using a detergent. Both the 
supernatants and the pellets of clones 23 and 25 were solubilized with 1% n-Dodecyl-β-D-
Maltoside (DDM) and analyzed by Western blot. The signal in positive control and no signal 
in the negative control confirmed that the analysis was correct. A strong signal in pellets in both 
clones and weak signal in the supernatant what we expected according to the previous 









3.6 Purification of the TgAPT from cell lysate on Strep-Tactin® resin 
To achieve affinity purification of APT, the protein sample of the pellet which contained 
more APT protein was solubilized with DDM and bound to a Strep-Tactin® matrix according 
to the manufacturer’s instruction (IBA, Germany). The bound TgAPT was eluted in ten 0.5 ml 
fractions with the elution buffer containing 25 mM desthiobiotin (DTB). The elution fractions 
were analyzed by SDS-PAGE and Western analysis with a Strep-Tactin® HRP-conjugated 
antibody. 
Figure 18 shows that no signal could be detected in the samples of the affinity 
purification, neither in the flow through nor in the eluted sample (Figure 18, lanes 25 F and 25 
E), although the APT could be detected in the supernatant and the pellet after cell lysis (Figure 





Figure 18. SDS-PAGE and Western blot analysis of a clone 25 after lysis and purification 
The marker was PageRuler™ Prestained Protein Ladder (Thermo Fisher Scientific, #SM0671);  N.C. - 
negative control non-induced clone 25; P.C. - positive control is the sample from the previous 











Therefore, the affinity purification was repeated with the protein pellet of an extract from 
newly induced E. coli cells of clone 25. Figure 19 shows that part of the APT protein was 
detected both in the flow through and the elution of the affinity chromatography (lanes 25 F 
and 25 E).  
 
 
Figure 19. a) Coomassie and b) Western blot analysis of a clone 25 after lysis and purification 
The marker was PageRuler™ Prestained Protein Ladder (Thermo Fisher Scientific, #SM0671); N.C. -
negative control non-induced clone 25; P.C.- positive control is the sample from the previous 
experiment; number 25 indicates the clone 25; P- pellet; S - supernatant; F - flow through; E - elution 
 
 
The next purification of the APT was done with the supernatant obtained after cell lysis 
of the clones 23 and 25 (Figure 20). No signal was detected in the flow through of the affinity 
purification, but a weak signal in the eluted samples. This indicates, that the APT protein in the 




Figure 20. Western blot analysis after purification on Strep-tactin resin; M - marker was the 
PageRuler™ Prestained Protein Ladder (Thermo Fisher Scientific, #SM0671); N.C. - negative control 
non-induced clone 25; P.C.- positive control is the sample from the previous experiment; numbers 





Around 30-50% of the world population is infected by the parasite Toxoplasma gondii 
(Pappas 2009), which causes the disease Toxoplasmosis. It can affect any warm-blooded animal 
and humans. It is rarely fatal for humans, but in individuals who have a weak immune system 
it can be fatal and lead to death (Flegr et al., 2014). T. gondii belongs to the group Apicomplexa, 
which also includes Plasmodium species, which are the causative agent for malaria, and 
Cryptosporidium spp. Which causes cryptosporidiosis. Most important apicomplexan genera in 
veterinary medicine and agriculture are parasites like Babesia spp. and Theileria spp. in cattle 
and Eimeria spp. (coccidiosis) in poultry. (Beck et al., 2009; Wiser 2011; Hikosaka et al., 
2013). T. gondii, as all other Apicomplexa, possesses a special plastid-like organelle called 
apicoplast discovered by Kohler in 1997. It is a vestigial plastid because it is not green and it 
does not perform photosynthesis (Kohler et al., 1997).  
The apicoplast is considered to be essential for the survival of the parasite. Beside its 
basic metabolic processes such as DNA replication, transcription and translation (Brooks et al., 
2011; Dahl and Rosenthal 2008), they also have enzymes involved in anabolic pathways like 
the synthesis of fatty acids, isoprenoids and haem (Ralph et al., 2004). These pathways are 
fundamentally different from the equivalent eukaryotic pathways of the animal or human hosts 
and that is why apicoplasts are interesting to study as potential drug targets (McFadden et al., 
1996).  
The malaria parasite possesses two APT transporters that are differentially localized to 
the inner and outer membrane of the apicoplast (Mullin et al., 2006). The T. gondii on the other 
hand has only one APT (TgAPT) (Karnataki et al., 2007; Fleige et al., 2007) that most likely 
localizes to the multiple membranes of the apicoplast. The TgAPT delivers carbon units, triose 
phosphates and phosphoenolpyruvate, for at least two different anabolic processes in the 
apicoplast, namely fatty acid synthesis and the DOXP pathway. It also has an essential role in 
indirectly supplying the apicoplasts with ATP and redox equivalents. The APT is therefore a 
metabolic hub that links cytosolic metabolism with essential processes in the apicoplast (Mullin 
et al., 2006; Brooks et al., 2010; Karnataki et al., 2007; Lim et al., 2010). 
The TgAPT had already been expressed in yeast (Brooks et al., 2010) and because protein 
production in yeast is time consuming and expensive we also wanted to produce the APT 
protein in a bacterial system, namely the model organism Escherichia coli and to establish the 
purification protocol for the protein. To obtain the best APT expression, the APT protein was 
expressed in six different E. coli strains (BL21 RIL, BL21 DE3, C41, C43, Rosetta PLys and 
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Rosetta). These cell strains have different properties, especially in the translation system. 
However, all chosen strains have a T7-based expression system. Here, the T7-RNA polymerase 
gene is under the control of the lacUV5 promoter and is induced by the addition of IPTG. The 
induced T7 polymerase is then transcribing the APT gene that is regulated by a T7 promoter. 
The results presented here clearly show that not all transformed E. coli strains are capable of 
expressing the protein (Figure 10). Only the BL21 RIL strain but none of the other strains 
expressed the APT protein. The BLR21 RIL strain possesses additional copies of the thre tRNA 
genes argU, ileY, and leuW. Thus, a lack of sufficient amounts of these tRNAs might explain 
the missing APT expression in the other strains. However, a more detailed analysis of the 
expression of the APT in several independently transformed BLR21 RIL cells showed that 
different clones differed significantly in their APT expression level, with a number of clones 
showing no expression at all while two (clones 23 and 25) showed a high expression level 
(Figure 12). These data reveal that the expression of membrane proteins in E. coli is difficult to 
achieve and that it is necessary to screen several strains and large number of independent clones 
for expression. 
For protein isolation, the E. coli cells were disrupted by sonication and the extract was 
centrifuged at low speed. The pellet represents in the insoluble material which is mainly 
unbroken cells and cell debris. It also contains unfolded and insoluble proteins which are 
concentrated in large "inclusion bodies". Heterologously expressed proteins are often found in 
these inclusion bodies. In contrast, the supernatant contains the soluble proteins and the 
membranes released from the cell. A total of 10 protein extraction experiments were performed 
(not all data shown). In each experiment the APT protein was present both in the pellets and 
the supernatants after cell lysis. One of the reasons for the occurrence of the APT protein in the 
pellet could be that the cells were not disrupted completely. The second reason is that part of 
the APT did not correctly fold into its native conformation and therefore is found in inclusion 
bodies. For example, during sonication much heat is produced causing protein denaturation. 
Therefore, the conditions during the process of cell lysis should be optimized or different 
techniques to break the cells like a French press or a beat beater should be used.  
One of the many properties that proteins have is the ability to bind to specific ligands. 
This property enables to separate specific proteins of interest from others in a mixture. Affinity 
chromatography is a type of liquid chromatography which is based on the highly specific 
interaction of a protein (or part of it) with another molecule that is attached to a matrix. The 
Strep-tag® system uses the Strep-tag® II tag which is a synthetic peptide consisting of eight 
amino acids (WSHPQFEK). This peptide sequence exhibits native affinity towards Strep-
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Tactin®, a specifically engineered streptavidin. It binds to the biotin binding pocket, enabling 






Figure 21. Schematic view of: 
1. biotin and streptavidin, 2. a protein with Strep-Tag II and Strep-Tactin® , 3. a protein with a Twin-
Strep-tag and Strep-Tactin® (IBA 2012). 
 
 
To achieve an affinity based purification, a new construct of the APT protein was used. 
Purification by streptavidin affinity chromatography turned out to be more efficient than NTA 
chromatography (unpublished data by Karsten Fischer). Therefore, the his6-tag and Strep-tag® 
II of the APT that had been expressed in yeast were replaced with the new Twin-Strep-tag®. 
This Twin-Strep-tag® (WSHPQFEK-GGGSGGGSGG-SAWSHPQFEK) is a short synthetic 
peptide which consists of two Strep-tag II moieties connected by a short linker and two amino 
acid spacer between the protein and the tag (see Introduction). The chromatography is then 
performed in three steps: sample loading, washing, and elution of the protein by a high 
concentration of a free ligand like biotin (Hage et al., 2013).  
In a first experiment, no APT signals were detected in a western blot analysis of the 
affinity chromatography, neither in the flow through nor in the eluted samples, although the 
APT protein was expressed in the E. coli cells (Figure 18). This suggests that there were 
problems with the solubilization of the membrane proteins and/or with the affinity purification.  
The affinity purification was repeated with the newly induced E. coli clone 25 and part 
of the APT protein was detected in the flow through and elution (Figure 19), indicating that part 
of the total APT protein content in the pellet has been successfully solubilized by the detergent 
DDM. However, only less than 50% of the solubilized protein was bound to the affinity column. 
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The reason could be that in part of the protein the affinity tag is not accessible because it is 
covered by the detergent.  
The APT protein from the supernatants of the clones 23 and 25 was also purified by 
affinity chromatography. Here, no signal was detected in the flow through and a week signal in 
the elution samples (Figure 20), indicating that APT protein in the supernatant can be 































5. Conclusion and future work 
 
Determination of the structures of membrane proteins is a challenging task that is essential to 
understand biological function at the molecular level. In order to provide insights into its 
biochemical properties, we tried to overexpress and purify the APT protein of Toxoplasma 
gondii. At present, the protein could not be completely purified. Therefore, several problem 
have to be solved in the future. These are the optimization of cell lysis, solubilization of the 
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Figure 22. The systemic diagram of the pET-21 b (+) vector 
The pET-21 b (+) vectors carry an N-terminal T7-Tag® sequence plus an optional C-terminal His-Tag® 
sequence. The f1 origin is oriented so that infection with helper phage will produce virions containing 
single-stranded DNA that corresponds to the coding strand. Therefore, single-stranded sequencing 
should be performed using the T7 terminator primer. Black arrow indicates the multiple cloning site; 
Ap- ampicillin resistance gene; ori- bacterial origin of replication; lacI- lactose operon repressor. Figure 
taken from Novagen pET system manual. 
 
 
 
 
